Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
88.89 CHF | +0.02% | +0.12% | +4.93% |
Apr. 29 | Novartis target Morphosys multiplies losses - takeover schedule stands | DP |
Apr. 29 | Morphosys says takeover by Novartis on course after report of drug safety concern | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.93% | 199B | |
+26.47% | 664B | |
+28.22% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.62% | 234B | |
-10.14% | 196B | |
-4.04% | 148B | |
-10.94% | 145B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- NOVARTIS AG : Goldman Sachs reaffirms its Buy rating